Transulnar Access: Another Ace Up Our Sleeve Before Transfemoral Access

Transulnar access can be as safe and effective as transradial access, and it is a particularly good alternative for the preservation of radial artery patency or when such vessel presents a difficult anatomy. This new meta-analysis that will be published soon in Catheter Cardiovasc Interv showed a relatively high failure rate for that access, but that could be easily explained by a learning curve.

El acceso cubital puede ser un as en la manga extra antes de pensar en el femoralIn terms of safety, neither excess bleeding/bruising nor other vascular complications were observed with transulnar access when compared with transradial access in patients who underwent angioplasty. However, the rate of failure for transulnar access more than doubled that for transradial access (odds ratio [OR]: 2.63).

 

This meta-analysis included 6 trials with about 4800 patients and showed that transulnar access was not associated with increased fluoroscopy time, contrast volume or access time.


Read also: Tips to Prevent Radial Occlusion after Catheterization.


Transulnar access can be considered an alternative in cases in which operators need to preserve the radial artery for bypass grafts or arteriovenous fistulae for patients with poor kidney function. Additionally, the ulnar artery tends to offer higher bore and lower tortuosity than the radial artery.

 

On the other hand, the transulnar artery is deeper and getting a pulse is often more difficult. If we only remember it when we run into problems with transradial access, we probably will not get the necessary experience in using this access site.

 

The ideal course of action seems to be the assessment of access on a case-by-case basis, depending on the relative size of the radial and ulnar arteries.


Read also: Transradial Access and Early Discharge in Percutaneous Interventions.


A common concern regarding this access is that the ulnar nerve lies right next to the artery through the Guyon canal, between the pisiform bone and the ulnar artery. Since, generally, the patient is positioned with his/her arm right next to his/her body, the puncture will always be more likely to fall on the free side of the artery (which is ideal) and not near the nerve. Pseudoaneurysms should also be taken into account, since the ulnar artery is deeper and there are no bony structures for good compression. In conclusion, until we gain sufficient experience, post-procedural monitoring should be closer than current monitoring of patients with transradial access.

 

Original title: Safety and Efficacy of Ulnar Artery Approach for Percutaneous Cardiac Catheterization: Systematic Review and Meta-Analysis.

Reference: Fernandez R et al. Catheter Cardiovasc Interv. 2018; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...